Waters Q4 Revenues Edge Up Slightly, Beat Street Estimate | GenomeWeb

NEW YORK (GenomeWeb) – Waters today reported that its fourth quarter revenues were up a fraction of a percent compared to the year-ago period.

For the three months ended Dec. 31, 2015, Waters' total revenues increased to $587 million from $584 million in Q4 2014, besting the consensus analyst estimate of $582 million.

The effect of foreign currency translation reduced Q4 revenues by 5 percent, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.